BF
TAK icon

BOK Financial’s Takeda Pharmaceutical TAK Stock Holding History

BOK Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$647 – 1498
2024
Q2 		$647 Hold
50
– – ﹤0.01% 1078
2024
Q1 		$684 Sell
50
-408
-89% -$5.93K ﹤0.01% 1102
2023
Q4 		$6.54K Hold
458
– – ﹤0.01% 994
2023
Q3 		$6.23K Buy
+458
New +$7.09K ﹤0.01% 939
2023
Q2 		– Sell
-796
Closed -$13.1K – 1173
2023
Q1 		$13.1K Buy
+796
New +$12.7K ﹤0.01% 974
2022
Q4 		– Sell
-10,313
Closed -$134K – 940
2022
Q3 		$134K Buy
+10,313
New +$143K ﹤0.01% 862
2019
Q3 		– Sell
-10,317
Closed -$183K – 945
2019
Q2 		$183K Sell
10,317
-18
-0.2% -$328 ﹤0.01% 867
2019
Q1 		$211K Buy
+10,335
New +$208K 0.01% 851

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BOK Financial's TAK Position: Q3 2024 in Review

BOK Financial sold out of Takeda Pharmaceutical (TAK) in Q3 2024, closing a stake of 50 shares — an estimated $647 sold.

BOK Financial first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $211K in Q1 2019. 298 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

  • BOK Financial reported no remaining Takeda Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • BOK Financial sold 50 Takeda Pharmaceutical shares in Q3 2024, an estimated $647.
  • BOK Financial first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • BOK Financial's Takeda Pharmaceutical position peaked at $211K in Q1 2019.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on BOK Financial's 13F filing for Q3 2024, filed 14 Nov 2024.